TriSalus Life Sciences, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TriSalus Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $42.63M.
- TriSalus Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $20.45M, a 467.77% increase year-over-year.
- TriSalus Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $5.65M, a 83.46% decline year-over-year.
- TriSalus Life Sciences, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $3.60M.
- TriSalus Life Sciences, Inc. stock issued during period, value, new issues for fiscal 2025 was $20.45M, a 32.16% increase from fiscal 2024.
- TriSalus Life Sciences, Inc. stock issued during period, value, new issues for fiscal 2024 was $15.47M, a 54.69% decline from fiscal 2023.
- TriSalus Life Sciences, Inc. stock issued during period, value, new issues for fiscal 2023 was $34.15M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $42.63M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $20.45M 10-K · filed 2026-03-05 | |
| 2025-06-30 | $20.45M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $15.47M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $5.65M 10-Q · filed 2025-11-13 | $12.40M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $3.60M 10-Q · filed 2025-11-13 | $40.90M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | $3.14M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $9.00K derived: 10-K 180 month − 10-Q 177 month · filed 2024-04-11 | $34.15M 10-K/A · filed 2025-05-30 |
| 2023-09-30 | $34.15M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |